MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Government: U.S. States & Territories
Government: States (U.S.)
Maryland
Metropolitan Areas: Maryland
Montgomery County, Maryland
*Industry: Montgomery County
*Industry: Rockville, Maryland
Human Genome Sciences (NASDAQ: HGSI), #5 (Biotech-Patent Board-2007),
Organization & Developments: Human Genome Sciences
Parents
Human Genome Sciences (NASDAQ: HGSI), #5 (Biotech-Patent Board-2007),
Children
*Lupus drug Benlysta from Human Genome Sciences forecasted to be potential 2011 blockbsuter
*Starting final testing for a lupus treatment
2011: 2nd UPDATE: FDA Approves Lupus Drug From Human Genome, Glaxo (2011)
2013: Albiglutide, diabetes drug key to Human Genome Sciences-GlaxoSmithKline merger, proves effective
Combined $555 million in anthrax contracts (2006)
Discovers, develops, manufactures and markets gene-based protein and antibody drugs to treat and cure disease
Early 2004, as pressure mounted on the company, Haseltine resigned
FivePrime Nabs $495M Deal With Human Genome Sciences to Develop Cancer Drug (2011)
Human Genome foresees multi-billion revenues (2011)
Human Genome Sciences is a biopharmaceutical company with the mission to discover, develop, manufacture and market new gene- and protein-based drugs.
Human Genome Sciences Shares Surge after $2.6B GlaxoSmithKline Buyout Offer Rejected (2012)
Human Genome Sciences:Business Areas
Human Genome Sciences:New Product and Business Developments
Human Genome Sciences:Organization
Jumps
*Key People: Human Genome Sciences
Finance & Acquisitions: Human Genome Sciences